Acromegaly Assessment and Therapeutics Analysis Forecast till 2024
Overview
Acromegaly is a hormonal disorder that develops when pituitary gland produces too much growth hormone during adulthood. Symptoms include body odor, easy fatigue, headache, large feet, excessive height, swelling of the bony areas around a joint, widely spaced teeth and sleep apnea. Treatment includes surgery, dopamine agonists and growth hormone antagonists.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2319064-acromegaly-pipeline-review-h2-2017
Top Companies mentioned
DexTech Medical AB
Foresee Pharmaceuticals LLC
Glide Pharmaceutical Technologies Ltd
Ionis Pharmaceuticals Inc
Midatech Pharma Plc
Novartis AG
Peptron Inc
Silence Therapeutics Plc
Acromegaly Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Acromegaly - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Acromegaly , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Filing rejected/Withdrawn, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 6, 4, 1, 6 and 3 respectively.
Acromegaly pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Acromegaly - Competitive Analysis
Key players are making innovative developments in Acromegaly industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Acromegaly.
The pipeline guide reviews pipeline therapeutics for Acromegaly by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Acromegaly therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Acromegaly therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Acromegaly.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2319064-acromegaly-pipeline-review-h2-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Thursday February 22 2018, 4:33 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
